Vaccines for poverty-related diseases (PRDs)

Basic Information

Network

EDCTP2

Website

https://www.edctp.org/funding-opportunities/

Aim of the joint call

The purpose of this call is to support large-scale collaborative projects which include one or more clinical trials (phase I to IV) aiming to accelerate the clinical development of new vaccines (preventive or therapeutic) against one of the PRDs. Applications must include at least one clinical trial which will be carried out in sub-Saharan Africa to test the safety, immunogenicity and/or efficacy of the vaccine(s).

Type of joint call

Two Stages - Call with pre-proposals and full proposals submissions

Events

-                                                Launch date
+/07/2016
-                                                Deadline Pre-Proposal
+/10/2016 Submitted proposal: 46
-                                                Deadline Full-Proposal
+/03/2017 Submitted proposal: n/a
-                                                Evaluation End Date
+                                                n/a
                                                Successful proposal: n/a
                                                Proposals funded: 7

Is call co-funded?

No

Call follow up funding

n/a

Call reasons

n/a

Research fields

n/a

Type of research

n/a

Target groups

n/a

Participating networks

n/a

Organisations Participating

No participating organisations found.

Funded Projects

Acronym	Title	Start	End	No. partners
MMVC	Multi-Stage Malaria Vaccine Consortium: field efficacy testi...	01/04/2018	30/09/2023	13
MTBVAC-Newborns	MTBVAC in Newborns: Phase 2a Dose-Defining Safety and Immuno...	01/01/2018	31/12/2020	6
NIFTY	Non-Inferiority Of Fractional-Doses Trial For Yellow-Fever-V...	01/04/2018	31/07/2021	4
POR TB	POR TB consortium; Phase 2 trial to determine efficacy of th...	01/11/2017	31/10/2022	8
PREV-PKDL	Clinical development of a therapeutic vaccine for prevention...	01/04/2018	30/06/2023	6
PrEPVacc	Weber A combination efficacy study in Africa of two DNA-MVA-...	01/01/2018	31/03/2023	14
priMe	A multicenter Phase III double-blind, randomized, controlled...	01/05/2018	30/04/2024	14